Surmodics

Surmodics Documents

Documents

100

Ticker

SRDX

ISIN

US8688731004

Revenue Net Income P/E P/S EBIT Dividend Directors Dealings Stocks Market capitalization Debt Liabilities Equity AAQS Employees ROE ROA ROCE News Documents

Surmodics SEC Filings

Type
Report
Date
15-12G15-12G-Formular12/1/2025
SCHEDULE 13G/ASCHEDULE 13G/A-Formular11/20/2025
SCHEDULE 13D/ASCHEDULE 13D/A-Formular11/20/2025
EFFECTEFFECT-Formular11/20/2025
4Insidertransaktion11/19/2025
4Insidertransaktion11/19/2025
S-8 POSS-8 POS-Formular11/19/2025
4Insidertransaktion11/19/2025
4Insidertransaktion11/19/2025
4Insidertransaktion11/19/2025
S-8 POSS-8 POS-Formular11/19/2025
S-8 POSS-8 POS-Formular11/19/2025
S-8 POSS-8 POS-Formular11/19/2025
S-8 POSS-8 POS-Formular11/19/2025
POS AMPOS AM-Formular11/19/2025
4Insidertransaktion11/19/2025
25-NSE25-NSE-Formular11/19/2025
4Insidertransaktion11/19/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben11/19/2025
4Insidertransaktion11/19/2025
4Insidertransaktion11/19/2025
4Insidertransaktion11/19/2025
4Insidertransaktion11/19/2025
S-8 POSS-8 POS-Formular11/19/2025
S-8 POSS-8 POS-Formular11/19/2025
S-8 POSS-8 POS-Formular11/19/2025
S-8 POSS-8 POS-Formular11/19/2025
S-8 POSS-8 POS-Formular11/19/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben11/12/2025
SCHEDULE 13G/ASCHEDULE 13G/A-Formular11/7/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben8/8/2025
10-QQuartalsbericht8/8/2025
SCHEDULE 13GSCHEDULE 13G-Formular7/15/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben7/2/2025
SDSD-Formular5/20/2025
SCHEDULE 13G/ASCHEDULE 13G/A-Formular5/14/2025
SCHEDULE 13G/ASCHEDULE 13G/A-Formular5/13/2025
10-QQuartalsbericht4/30/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben4/30/2025
SCHEDULE 13G/ASCHEDULE 13G/A-Formular3/21/2025
SCHEDULE 13DSCHEDULE 13D-Formular3/19/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben3/7/2025
4Insidertransaktion2/20/2025
4Insidertransaktion2/18/2025
4Insidertransaktion2/18/2025
SCHEDULE 13GSCHEDULE 13G-Formular2/14/2025
SCHEDULE 13G/ASCHEDULE 13G/A-Formular2/13/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben2/10/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben1/30/2025
10-QQuartalsbericht1/30/2025
4Insidertransaktion1/28/2025
SCHEDULE 13GSCHEDULE 13G-Formular1/22/2025
DEFA14ADEFA14A-Formular12/19/2024
DEF 14ADEF 14A-Formular12/19/2024
4Insidertransaktion12/6/2024
4Insidertransaktion12/6/2024
4Insidertransaktion12/6/2024
4Insidertransaktion12/6/2024
4Insidertransaktion12/6/2024
4Insidertransaktion12/6/2024
4Insidertransaktion12/6/2024
4Insidertransaktion12/3/2024
4Insidertransaktion12/3/2024
4Insidertransaktion12/3/2024
4Insidertransaktion12/3/2024
4Insidertransaktion12/3/2024
4Insidertransaktion12/3/2024
4Insidertransaktion12/3/2024
4Insidertransaktion11/27/2024
144144-Formular11/26/2024
10-KJahresbericht11/20/2024
SCHEDULE 13GSCHEDULE 13G-Formular11/15/2024
SC 13G/ABeneficial ownership report11/14/2024
SC 13G/ABeneficial ownership report11/6/2024
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben11/6/2024
SC 13G/ABeneficial ownership report10/23/2024
SC 13G/ABeneficial ownership report10/23/2024
4Insidertransaktion8/23/2024
4Insidertransaktion8/23/2024
4Insidertransaktion8/20/2024
4Insidertransaktion8/20/2024
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben8/8/2024
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben7/31/2024
10-QQuartalsbericht7/31/2024
SC 13G/ABeneficial ownership report7/9/2024
DEFM14ADEFM14A-Formular7/8/2024
PREM14APREM14A-Formular6/27/2024
SC 13GSC 13G-Formular6/10/2024
DEFA14ADEFA14A-Formular5/29/2024
DEFA14ADEFA14A-Formular5/29/2024
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben5/29/2024
SDSD-Formular5/24/2024
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben5/1/2024
10-QQuartalsbericht5/1/2024
SC 13G/ABeneficial ownership report2/13/2024
4Insidertransaktion2/12/2024
4Insidertransaktion2/12/2024
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben2/12/2024
4Insidertransaktion2/12/2024
4Insidertransaktion2/12/2024

Surmodics Documents 2026

This page contains all official documents and SEC filings for Surmodics stock (SRDX, ISIN: US8688731004). This includes annual reports (Form 10-K), quarterly reports (Form 10-Q), and insider transactions (Form 4). Currently 100 documents are available. Data is updated regularly to provide investors with a complete overview of Surmodics's regulatory filings.

Surmodics Stock analysis

Surmodics Surmodics Inc is an American company specializing in medical technology, based in Eden Prairie, Minnesota. They focus on developing and commercializing technologies to improve disease diagnosis and treatment. The company offers a wide range of medical devices and solutions for various medical applications, including cardiology, radiology, oncology, ophthalmology, and pharmaceutical development. Surmodics operates in three main business areas: medical devices, hollow fiber technology, and bioactive coatings. Their products are designed to meet the specific needs of customers and medical applications. Surmodics has a strong global presence and has expanded through strategic acquisitions in recent years, particularly in the pharmaceutical development and hollow fiber technology sectors.